Get started
333

ZHONGZHI PHARMACEUTICAL HLDGS LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

3737 chart


Full chart

3737 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪787.71 M‬ HKD
Dividend yield (indicated)
3.23%
Price to earnings Ratio (TTM)
6.54
Basic EPS (TTM)
0.14 HKD
Net income (FY)
‪179.87 M‬ HKD
Revenue (FY)
‪2.27 B‬ HKD
Shares float
‪283.75 M‬
Beta (1Y)
0.30

Employees


Employees (FY)
‪2.64 K‬
Change (1Y)
−240 −8.32%
Revenue / Employee (1Y)
‪109.72 K‬ HKD
Net income / Employee (1Y)
‪8.71 K‬ HKD

About ZHONGZHI PHARMACEUTICAL HLDGS LTD


Sector
Health Technology
CEO
Ying Feng Lai
Headquarters
Zhongshan
Website
zeus.cn
Founded
2014
FIGI
BBG009J4NMV3
Zhongzhi Pharmaceutical Holdings Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. The Pharmaceutical Manufacturing segment deals with the research, development, manufacturing, and sale of Chinese patent medicines and decoction pieces. The Operation of Chain Pharmacies segment manages self-operated chain and medical insurance designated pharmacies. The company was founded by Zhi Tian Lai on September 12, 2014 and is headquartered in Zhongshan, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

3737 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 3737 is 0.93 HKD — it has decreased by −3.23% in the past 24 hours. Watch ZHONGZHI PHARMACEUTICAL HLDGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ZHONGZHI PHARMACEUTICAL HLDGS LTD stocks are traded under the ticker 3737.
3737 stock has fallen by −1.10% compared to the previous week, the last month showed zero change in price, over the last year ZHONGZHI PHARMACEUTICAL HLDGS LTD has showed a −35.42% decrease.
3737 reached its all-time high on Jul 31, 2015 with the price of 2.80 HKD, and its all-time low was 0.70 HKD and was reached on Mar 15, 2022. View more price dynamics on 3737 chart.
See other stocks reaching their highest and lowest prices.
3737 stock is 3.26% volatile and has beta coefficient of 0.30. Track ZHONGZHI PHARMACEUTICAL HLDGS LTD stock price on the chart and check out the list of the most volatile stocks — is ZHONGZHI PHARMACEUTICAL HLDGS LTD there?
Today ZHONGZHI PHARMACEUTICAL HLDGS LTD has the market capitalization of ‪786.13 M‬, it has increased by 1.09% over the last week.
Yes, you can track ZHONGZHI PHARMACEUTICAL HLDGS LTD financials in yearly and quarterly reports right on TradingView.
ZHONGZHI PHARMACEUTICAL HLDGS LTD is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
3737 net income for the last half-year is ‪90.42 M‬ HKD, while the previous report showed ‪30.11 M‬ HKD of net income which accounts for 200.25% change. Track more ZHONGZHI PHARMACEUTICAL HLDGS LTD financial stats to get the full picture.
ZHONGZHI PHARMACEUTICAL HLDGS LTD dividend yield was 6.34% in 2023, and payout ratio reached 42.37%. The year before the numbers were 8.26% and 61.60% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has ‪2.64 K‬ employees. See our rating of the largest employees — is ZHONGZHI PHARMACEUTICAL HLDGS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZHONGZHI PHARMACEUTICAL HLDGS LTD EBITDA is ‪324.76 M‬ HKD, and current EBITDA margin is 13.18%. See more stats in ZHONGZHI PHARMACEUTICAL HLDGS LTD financial statements.
Like other stocks, 3737 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHONGZHI PHARMACEUTICAL HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHONGZHI PHARMACEUTICAL HLDGS LTD technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHONGZHI PHARMACEUTICAL HLDGS LTD stock shows the sell signal. See more of ZHONGZHI PHARMACEUTICAL HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.